A business in context
ROIV research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-20 | Pulik Richard | F · Tax / exercise payment | Common Shares | 2129.0 | 39.77 |
| 2026-09-20 | Humes Jennifer | F · Tax / exercise payment | Common Shares | 3880.0 | 39.77 |
| 2026-09-16 | Epperly Melissa B, | A · Grant / award | Common Shares | 5054.0 | 0.0 |
| 2026-09-16 | Epperly Melissa B, | A · Grant / award | Stock Option (Right to Buy) | 10531.0 | 0.0 |
| 2026-09-16 | Gold Daniel Allen | A · Grant / award | Common Shares | 5054.0 | 0.0 |
| 2026-09-16 | Gold Daniel Allen | A · Grant / award | Stock Option (Right to Buy) | 10531.0 | 0.0 |
| 2026-09-16 | Oren Ilan | A · Grant / award | Common Shares | 5054.0 | 0.0 |
| 2026-09-16 | Oren Ilan | A · Grant / award | Stock Option (Right to Buy) | 10531.0 | 0.0 |
| 2026-09-16 | Fitzgerald Meghan | A · Grant / award | Common Shares | 5054.0 | 0.0 |
| 2026-09-16 | Fitzgerald Meghan | A · Grant / award | Stock Option (Right to Buy) | 10531.0 | 0.0 |
| 2026-09-16 | MOMTAZEE JAMES C | A · Grant / award | Common Shares | 5054.0 | 0.0 |
| 2026-09-16 | MOMTAZEE JAMES C | A · Grant / award | Stock Option (Right to Buy) | 10531.0 | 0.0 |
| 2026-09-16 | MANCHESTER KEITH S | A · Grant / award | Common Shares | 5054.0 | 0.0 |
| 2026-09-16 | MANCHESTER KEITH S | A · Grant / award | Stock Option (Right to Buy) | 10531.0 | 0.0 |
| 2026-09-15 | Epperly Melissa B, | S · Sale | Common Shares | 4338.0 | 39.65 |
| 2026-09-15 | Epperly Melissa B, | S · Sale | Common Shares | 600.0 | 40.38 |
| 2026-09-15 | Fitzgerald Meghan | S · Sale | Common Shares | 400.0 | 40.45 |
| 2026-09-15 | Fitzgerald Meghan | S · Sale | Common Shares | 4712.0 | 39.68 |
| 2026-09-10 | Epperly Melissa B, | F · Tax / exercise payment | Common Shares | 2179.0 | 40.94 |
| 2026-09-10 | Oren Ilan | F · Tax / exercise payment | Common Shares | 2378.0 | 40.94 |
| 2026-09-10 | Fitzgerald Meghan | F · Tax / exercise payment | Common Shares | 1743.0 | 40.94 |
| 2026-09-10 | MOMTAZEE JAMES C | F · Tax / exercise payment | Common Shares | 2905.0 | 40.94 |
| 2026-09-10 | Gold Daniel Allen | F · Tax / exercise payment | Common Shares | 5133.0 | 40.94 |
| 2026-09-08 | Fitzgerald Meghan | S · Sale | Common Shares | 20000.0 | 39.9 |
| 2026-09-08 | Fitzgerald Meghan | M · Exercise / conversion | Common Shares | 20000.0 | 8.8 |
| 2026-09-08 | Fitzgerald Meghan | M · Exercise / conversion | Stock Option (Right to Buy) | 20000.0 | 0.0 |
| 2026-08-28 | Venker Eric | S · Sale | Common Shares | 166182.0 | 35.63 |
| 2026-08-28 | Venker Eric | M · Exercise / conversion | Common Shares | 200000.0 | 3.85 |
| 2026-08-28 | Venker Eric | S · Sale | Common Shares | 33818.0 | 36.44 |
| 2026-08-28 | Venker Eric | M · Exercise / conversion | Stock Option (Right to Buy) | 200000.0 | 0.0 |
| 2026-08-21 | Sukhatme Mayukh | S · Sale | Common Shares | 144756.0 | 36.48 |
| 2026-08-21 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 144756.0 | 3.85 |
| 2026-08-21 | Sukhatme Mayukh | M · Exercise / conversion | Stock Option (Right to Buy) | 144756.0 | 0.0 |
| 2026-08-20 | Pulik Richard | F · Tax / exercise payment | Common Shares | 5749.0 | 36.84 |
| 2026-08-20 | Venker Eric | F · Tax / exercise payment | Common Shares | 13909.0 | 36.84 |
| 2026-08-20 | Sukhatme Mayukh | S · Sale | Common Shares | 17519.0 | 37.3 |
| 2026-08-20 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 17519.0 | 3.85 |
| 2026-08-20 | Sukhatme Mayukh | M · Exercise / conversion | Stock Option (Right to Buy) | 17519.0 | 0.0 |
| 2026-08-19 | Sukhatme Mayukh | S · Sale | Common Shares | 172899.0 | 37.17 |
| 2026-08-19 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 172899.0 | 3.85 |
| 2026-08-19 | Sukhatme Mayukh | M · Exercise / conversion | Stock Option (Right to Buy) | 172899.0 | 0.0 |
| 2026-08-18 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 105141.0 | 3.85 |
| 2026-08-18 | Sukhatme Mayukh | S · Sale | Common Shares | 105141.0 | 36.59 |
| 2026-08-18 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 31801.0 | 3.85 |
| 2026-08-18 | Sukhatme Mayukh | S · Sale | Common Shares | 31801.0 | 37.18 |
| 2026-08-18 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 136942.0 | 0.0 |
| 2026-08-17 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 284707.0 | 3.85 |
| 2026-08-17 | Sukhatme Mayukh | S · Sale | Common Shares | 284707.0 | 36.25 |
| 2026-08-17 | Sukhatme Mayukh | M · Exercise / conversion | Common Shares | 284707.0 | 0.0 |
| 2026-08-14 | Sukhatme Mayukh | S · Sale | Common Shares | 243177.0 | 36.23 |
Identity & relationships
SEC issuer · 0001635088Roivant Sciences Ltd.
Search names and former names
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2025-03-31 | $29.05M | $31.00M |
| 2024-03-31 | $32.71M | $35.89M |
| 2023-03-31 | $31.53M | $35.80M |
| 2022-03-31 | $55.29M | $67.45M |
| 2021-03-31 | $23.80M | $30.83M |